wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37650748-204C766C-E573-4351-9A39-028536A95946
Q37650748-204C766C-E573-4351-9A39-028536A95946
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37650748-204C766C-E573-4351-9A39-028536A95946
Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen.
P2860
Q37650748-204C766C-E573-4351-9A39-028536A95946
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37650748-204C766C-E573-4351-9A39-028536A95946
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
64127c0a58132b8e42233e8c583fbca03457c2f8
P2860
Appraising iniparib, the PARP inhibitor that never was--what must we learn?